Morgan Stanley’s projection that global mergers and acquisitions will reach a record $6.4 trillion in 2026 — surpassing the previous peak set in 2021 — is not merely a headline figure. It is a strategic signal for CFOs, General Counsel, and M&A Directors who must now position their organisations ahead of an accelerating deal cycle. Buoyant equity markets, renewed corporate confidence, and structural sector shifts are converging to create one of the most active transactional environments in modern corporate finance history.

Structural Drivers: AI, Life Sciences, and the New Acquisition Logic

The current wave of cross-border deals is not cyclical opportunism — it is largely strategic and sector-specific. Two transactions illustrate this clearly. German pharmaceutical group Merck KGaA’s $11.3 billion acquisition of U.S.-based Bio-Techne reflects the intensifying race to consolidate life sciences capabilities across the Atlantic. Simultaneously, ON Semiconductor’s $7 billion all-stock acquisition of Synaptics signals how semiconductor players are repositioning around AI-enabled device architectures.

In the defence and dual-use technology segment, French group Safran has entered exclusive negotiations to acquire sea drone manufacturer Exail Technologies at €128.5 per share, underscoring how European defence primes are using M&A to rapidly internalise sovereign technology capabilities. These transactions share a common logic: acquiring proprietary technology stacks rather than building them organically, compressing time-to-market in sectors where competitive windows are narrowing.

For deal teams, this environment demands a rigorous recalibration of due diligence frameworks. Traditional financial and legal review must now integrate deep technology assessments — including IP ownership structures, AI model governance, and export control exposure — particularly in cross-border transactions involving U.S. and EU counterparties.

Regulatory Headwinds: EU Antitrust and U.S. National Security Scrutiny Are Intensifying

Record deal volume does not mean frictionless execution. Regulatory scrutiny on both sides of the Atlantic is escalating, and deal timelines are extending accordingly.

The EU Commission has launched a full-scale antitrust investigation into the proposed merger between Saipem and Subsea 7, two major players in the offshore energy services sector. The probe reflects Brussels’ continued vigilance over market concentration in strategically sensitive industries. For M&A Directors structuring European cross-border deals, this reinforces the need to conduct detailed competition analysis — including market share modelling and remedies planning — well before signing.

In the United States, the Treasury Department has validated national security concerns over Broadcom’s unsolicited proposal to acquire Qualcomm, invoking CFIUS-adjacent review mechanisms. This is a critical reminder that technology-intensive acquisitions, particularly those involving semiconductor IP, telecommunications infrastructure, or dual-use components, face a materially different regulatory calculus than consumer or services transactions.

  • Pre-filing engagement with competition authorities in the EU and FTC/DOJ in the U.S. is no longer optional for deals above relevant thresholds.
  • CFIUS and FDI screening timelines must be built into deal structuring from day one, not treated as a post-signing formality.
  • Remedy packages — including behavioural and structural commitments — should be modelled as part of initial transaction economics.

Private Equity Acceleration: From Mid-Market to Consumer Infrastructure

Private equity is operating with renewed aggression. KKR’s acquisition of EDF’s U.S. and Canada Power Solutions unit and Apollo Global Management’s £5.7 billion takeover bid for easyJet — outbidding rival Castlelake — demonstrate that top-tier PE firms are moving decisively into energy transition assets and consumer infrastructure across Europe and North America.

In the mid-market, H.B. Fuller’s £715 million acquisition of Advanced Medical Solutions Group is representative of a broader pattern: U.S. strategic buyers using strong dollar valuations to consolidate specialised European assets at attractive multiples. For European boards and management teams, this creates both opportunity and urgency around post-merger integration planning and vendor-side preparation.

Implications for Decision-Makers

As deal velocity increases, execution quality becomes a differentiating factor. Organisations that will capture value in the 2025–2026 M&A cycle are those investing now in:

  • Integration readiness: post-merger integration frameworks that address technology stack consolidation, workforce alignment, and regulatory harmonisation across jurisdictions.
  • Regulatory intelligence: real-time monitoring of EU, U.S., and UK regulatory developments affecting target sectors.
  • Financing structure agility: the ability to deploy all-stock, cash, or hybrid structures depending on market conditions and counterparty preferences.

Key Takeaway: The $6.4 trillion M&A forecast is not a passive market condition — it is a competitive environment where preparation, regulatory sophistication, and integration capability will determine who creates lasting value and who destroys it. For European deal makers operating in cross-border contexts, the window to build these capabilities is now.